In a groundbreaking development for rheumatoid arthritis treatment, Lifordi Immunotherapeutics, a clinical-stage biotech firm headquartered in Burlington, Massachusetts, has successfully raised $112 million in a funding round led by Sanofi Ventures, with continued support from prominent investors
Spinal Muscular Atrophy (SMA), a rare genetic disorder that causes progressive muscle weakness and significant life challenges, has long been a focus of medical research seeking transformative solutions for affected individuals across all ages. A pivotal moment in this journey arrived on November
Diving into the complex world of radiation-induced brain injury (RIBI), we’re thrilled to speak with a leading expert in radiation oncology and neuroimaging. With years of experience in both clinical practice and cutting-edge research, our guest today has dedicated their career to understanding the
In a world where medical advancements have conquered countless diseases, a silent yet deadly threat looms large—drug-resistant fungal infections are claiming millions of lives each year, often with little public attention. These infections strike hardest at the most vulnerable, such as cancer
In a groundbreaking moment for the biotechnology sector, San Diego-based startup Iambic has captured the spotlight by raising an impressive $100 million in Series B financing to propel clinical trials of its AI-discovered cancer drugs, marking a significant milestone for the company. This
In a monumental step forward for medical science, the announcement of the world’s first clinical trial for a lung cancer prevention vaccine, known as LungVax, marks a turning point in the battle against one of the deadliest diseases globally, with the trial slated to commence in 2026. Developed
